trending Market Intelligence /marketintelligence/en/news-insights/trending/5lm9igtnt2byafcjvews1w2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Northwest Biotherapeutics to raise $10M in direct offering

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Northwest Biotherapeutics to raise $10M in direct offering

Northwest Biotherapeutics Inc. is selling 28.6 million common shares at 35 cents per share in a registered direct offering to institutional investors for gross proceeds of $10 million.

The investors will also receive warrants to buy up to about 14.3 million shares with an exercise price of 35 cents per share and an exercise period of five years.

The placement is expected to close on or about Dec. 23, subject to satisfaction of customary closing conditions.

Chardan Capital Markets LLC acted as the exclusive placement agent for the transaction.